| Phase 4 |
| NCT03087032 |
Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients… |
Type 2 Diabetes Patients |
Recruiting |
| NCT07165158 |
The Effect of Semaglutide on Bone Health |
Osteoporosis |
Not Yet Recruiting |
| Phase 3 |
| NCT06188455 |
Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent… |
Ovarian Cancer |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06068179 |
Graves' Disease Remission Study: MycoMeth Combo |
Graves' Disease |
Recruiting |
| Phase 2 |
| NCT05970666 |
Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and… |
Adebrelimab |
Recruiting |
| NCT06387056 |
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) |
Locally Advanced Prostate Cancer |
Recruiting |
| NCT06415669 |
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal… |
Gastric/Gastroesophageal Junction Adenocarcinoma |
Recruiting |
| NCT06553352 |
Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma |
Follicular Lymphoma |
Recruiting |
| NCT06584006 |
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for… |
Hematological Malignancy |
Recruiting |
| NCT06581640 |
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of… |
Multiple Myeloma |
Recruiting |
| NCT06826118 |
Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma |
Lymphoma |
Recruiting |
| NCT05603884 |
VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly… |
Leukemia, Myeloid, Acute |
Recruiting |
| NCT06151080 |
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL |
DLBCL - Diffuse Large B Cell Lymphoma |
Recruiting |
| NCT06151106 |
Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell… |
Peripheral T Cell Lymphoma |
Recruiting |
| NCT06158386 |
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular… |
Follicular Lymphoma |
Recruiting |
| NCT06158399 |
AZA Combined With RCHOP in P53-mutated DLBCL. |
DLBCL - Diffuse Large B Cell Lymphoma |
Recruiting |
| NCT06158412 |
All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of… |
Multiple Myeloma in Relapse |
Recruiting |
| NCT06827899 |
Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in… |
Acute Myeloid Leukemia |
Recruiting |
| NCT06929936 |
Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally… |
Non-Small Cell Lung Cancer |
Recruiting |
| NCT06676722 |
SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic… |
Nasopharyngeal Cancinoma (NPC) |
Recruiting |
| NCT06811844 |
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and… |
Nasopharyngeal Neoplasms |
Recruiting |
| NCT06651853 |
Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory… |
Diffuse Large B-cell Lymphoma |
Recruiting |
| NCT07085234 |
Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPC |
Locally Advanced Nasopharyngeal Carcinoma |
Recruiting |
| NCT05305859 |
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML |
Leukemia, Myeloid, Acute |
Recruiting |
| NCT06992739 |
Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced… |
NSCLC (Advanced Non-small Cell Lung Cancer) |
Recruiting |